Ranibizumab Intraocular and Vaseretic 10-25
Determining the interaction of Ranibizumab Intraocular and Vaseretic 10-25 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: enalapril / hydrochlorothiazide
Brand name: Vaseretic 10-25, Vaseretic 5-125
Synonyms: Vaseretic
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Vaso Dose Pack
- Ranibizumab Intraocular-Vasocidin
- Ranibizumab Intraocular-Vasoclear
- Ranibizumab Intraocular-Vasocon
- Ranibizumab Intraocular-Vasodilan
- Ranibizumab Intraocular-Vasoflex HD
- Vaseretic 10-25-Ranibizumab ophthalmic
- Vaseretic 10-25-Ranitidine
- Vaseretic 10-25-Ranitidine Capsule
- Vaseretic 10-25-Ranitidine Hydrochloride
- Vaseretic 10-25-Ranitidine Injection
- Vaseretic 10-25-Ranitidine Suspension